Bosley Katrine 4
4 · Editas Medicine, Inc. · Filed Dec 6, 2018
Insider Transaction Report
Form 4
Bosley Katrine
DirectorPresident and CEO10% Owner
Transactions
- Sale
Common Stock
2018-12-03$31.92/sh−11,900$379,848→ 1,217,066 total - Sale
Common Stock
2018-12-03$32.39/sh−100$3,239→ 1,216,966 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2017, as amended.
- [F2]This transaction was executed in multiple trades at prices ranging from $31.36 to $32.28. The price reported above reflected the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.